Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Devroe Eric had 613 Acrivon Therapeutics, Inc. shares withheld for tax (Form 4)
Traded May 14, 2026 · Filed May 18, 2026
On May 14, 2026, Devroe Eric (Chief Operating Officer) had 613 Acrivon Therapeutics, Inc. shares withheld for tax at US$1.92 for US$1,177, leaving 73,972 shares. Filed May 18, 2026 (Form 4).
- Withheld for tax
- 613 shares
- Price
- US$1.92
- Value
- US$1,177
- Holding after
- 73,972 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Shares withheld for tax | 613 | US$1.92 | 73,972 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Devroe Eric
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Devroe Eric · Aug 20, 2026
- Form 4 · Devroe Eric · May 20, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026